Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Polydeoxyribonucleotides
Therapeutic Area : Dermatology
Study Phase : Phase IV
Sponsor : Sintesi Research Srl
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy and Safety of PLACENTEX ® i.m. in Patients With Scleroderma Diseases
Details : Undisclosed
Product Name : Undisclosed
Product Type : Oligonucleotide
Upfront Cash : Inapplicable
January 02, 2018
Lead Product(s) : Polydeoxyribonucleotides
Therapeutic Area : Dermatology
Highest Development Status : Phase IV
Sponsor : Sintesi Research Srl
Deal Size : Inapplicable
Deal Type : Inapplicable